{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T20:09:46Z","timestamp":1783541386852,"version":"3.55.0"},"reference-count":210,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,9,5]],"date-time":"2023-09-05T00:00:00Z","timestamp":1693872000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Psychiatry"],"abstract":"<jats:p>Major depressive disorder (MDD) and other mental health issues pose a substantial burden on the workforce. Approximately half a million Canadians will not be at work in any week because of a mental health disorder, and more than twice that number will work at a reduced level of productivity (presenteeism). Although it is important to determine whether work plays a role in a mental health condition, at initial presentation, patients should be diagnosed and treated per appropriate clinical guidelines. However, it is also important for patient care to determine the various causes or triggers including work-related factors. Clearly identifying the stressors associated with the mental health disorder can help clinicians to assess functional limitations, develop an appropriate care plan, and interact more effectively with worker\u2019s compensation and disability programs, as well as employers. There is currently no widely accepted tool to definitively identify MDD as work-related, but the presence of certain patient and work characteristics may help. This paper seeks to review the evidence specific to depression in the workplace, and provide practical tips to help clinicians to identify and treat work-related MDD, as well as navigate disability issues.<\/jats:p>","DOI":"10.3389\/fpsyt.2023.1207653","type":"journal-article","created":{"date-parts":[[2023,9,5]],"date-time":"2023-09-05T09:18:10Z","timestamp":1693905490000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":12,"title":["Practical pathway for the management of depression in the workplace: a Canadian perspective"],"prefix":"10.3389","volume":"14","author":[{"given":"Pratap","family":"Chokka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ash","family":"Bender","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Brennan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghalib","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Corbi\u00e8re","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J. A.","family":"Dozois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeff","family":"Habert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Harrison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin A.","family":"Katzman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger S.","family":"McIntyre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang S.","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Nieuwenhuijsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyn S.","family":"Dewa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,9,5]]},"reference":[{"key":"ref1","unstructured":"WilkersonB\n          2006"},{"key":"ref2","unstructured":"2016"},{"key":"ref3","unstructured":"2013"},{"key":"ref4","unstructured":"2017"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1001\/jamapsychiatry.2022.3860","article-title":"Association of treatment-resistant depression with patient outcomes and health care resource utilization in a population-wide study","volume":"80","author":"Lundberg","year":"2023","journal-title":"JAMA Psychiat"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1111\/acps.13414","article-title":"Clinical and societal burden of incident major depressive disorder: a population-wide cohort study in Stockholm","volume":"146","author":"Lundberg","year":"2022","journal-title":"Acta Psychiatr Scand"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1186\/s12888-022-04165-x","article-title":"Humanistic and economic burden associated with depression in the United States: a cross-sectional survey analysis","volume":"22","author":"Jain","year":"2022","journal-title":"BMC Psychiatry"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1080\/13696998.2023.2172282","article-title":"Productivity loss and productivity loss costs to United States employers due to priority conditions: a systematic review","volume":"26","author":"Rojanasarot","year":"2023","journal-title":"J Med Econ"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1002\/wps.20767","article-title":"Preventing suicide in the context of the COVID-19 pandemic","volume":"19","author":"McIntyre","year":"2020","journal-title":"World Psychiatry"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"113104","DOI":"10.1016\/j.psychres.2020.113104","article-title":"Projected increases in suicide in Canada as a consequence of COVID-19","volume":"290","author":"McIntyre","year":"2020","journal-title":"Psychiatry Res"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.15585\/mmwr.mm6932a1","article-title":"Mental health, substance use, and suicidal ideation during the COVID-19 pandemic - United States, June 24-30, 2020","volume":"69","author":"Czeisler","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"e2019686","DOI":"10.1001\/jamanetworkopen.2020.19686","article-title":"Prevalence of depression symptoms in us adults before and during the COVID-19 pandemic","volume":"3","author":"Ettman","year":"2020","journal-title":"JAMA Netw Open"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1037\/cap0000251","article-title":"Anxiety and depression in Canada during the COVID-19 pandemic: a national survey","volume":"62","author":"Dozois","year":"2021","journal-title":"Can Psychol"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1186\/s12888-022-04158-w","article-title":"Impact of the COVID-19 pandemic on suicidal attempts and death rates: a systematic review","volume":"22","author":"Pathirathna","year":"2022","journal-title":"BMC Psychiatry"},{"key":"ref15","unstructured":"2019"},{"key":"ref16","unstructured":"2013"},{"key":"ref17","unstructured":"2022"},{"key":"ref18","first-page":"13","article-title":"Restoring function in MDD: balancing efficacy and tolerability to optimally manage major depressive disorder","volume":"28","author":"Bender","year":"2011","journal-title":"Can J Diagnosis"},{"key":"ref19","first-page":"9","article-title":"Psychiatric disability requires careful clinical management","volume":"4","author":"Bender","year":"2008","journal-title":"Can Psychiatry Aujourdhui"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1177\/070674371506000105","article-title":"Depression and employment status in primary and tertiary care settings","volume":"60","author":"Rizvi","year":"2015","journal-title":"Can J Psychiatr"},{"key":"ref21","volume-title":"Healthy brains at work: Estimating the impact of workplace mental health benefits and programs","author":"Sutherland","year":"2016"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1007\/s00127-016-1278-4","article-title":"Global patterns of workplace productivity for people with depression: absenteeism and presenteeism costs across eight diverse countries","volume":"51","author":"Evans-Lacko","year":"2016","journal-title":"Soc Psychiatry Psychiatr Epidemiol"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1007\/s00127-022-02240-y","article-title":"Functional status and return to work in people with major depression: a 3-year national follow-up study","volume":"57","author":"Hong","year":"2022","journal-title":"Soc Psychiatry Psychiatr Epidemiol"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s00420-022-01906-z","article-title":"The linkage of depressive and anxiety disorders with the expected labor market affiliation (ELMA): a longitudinal multi-state study of Danish employees","volume":"96","author":"Pedersen","year":"2023","journal-title":"Int Arch Occup Environ Health"},{"key":"ref25","unstructured":"2015"},{"key":"ref26","unstructured":"WaddellG\n            BurtonA\n          2006"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1080\/13696998.2020.1776297","article-title":"Economic and humanistic burden associated with noncommunicable diseases among adults with depression and anxiety in the United States","volume":"23","author":"Armbrecht","year":"2020","journal-title":"J Med Econ"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"113577","DOI":"10.1016\/j.psychres.2020.113577","article-title":"\u2018The dual pandemic\u2019 of suicide and COVID-19: a biopsychosocial narrative of risks and prevention","volume":"295","author":"Banerjee","year":"2021","journal-title":"Psychiatry Res"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/S2215-0366(16)30024-4","article-title":"Scaling-up treatment of depression and anxiety: a global return on investment analysis","volume":"3","author":"Chisholm","year":"2016","journal-title":"Lancet Psychiatry"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"461","DOI":"10.3233\/WOR-193008","article-title":"A systematic review of work accommodations for people with mental disorders","volume":"64","author":"Zafar","year":"2019","journal-title":"Work"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1097\/JOM.0b013e31822cfd82","article-title":"Perceived needs for and use of workplace accommodations by individuals with a depressive and\/or anxiety disorder","volume":"53","author":"Wang","year":"2011","journal-title":"J Occup Environ Med"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1097\/JOM.0b013e31829fd065","article-title":"Receiving workplace mental health accommodations and the outcome of mental disorders in employees with a depressive and\/or anxiety disorder","volume":"55","author":"Bolo","year":"2013","journal-title":"J Occup Environ Med"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1017\/S1092852919000853","article-title":"Canadian economic impact of improved workplace productivity in patients with major depressive disorder treated with vortioxetine","volume":"25","author":"Lachaine","year":"2019","journal-title":"CNS Spectr"},{"key":"ref34","first-page":"175","article-title":"Worker attitudes towards mental health problems and disclosure","volume":"5","author":"Dewa","year":"2014","journal-title":"Int J Occup Environ Med"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1007\/s00127-018-1561-7","article-title":"Psychiatric diagnosis and other predictors of experienced and anticipated workplace discrimination and concealment of mental illness among mental health service users in England","volume":"53","author":"Yoshimura","year":"2018","journal-title":"Soc Psychiatry Psychiatr Epidemiol"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"495","DOI":"10.3233\/WOR-205181","article-title":"Association of stigmatizing attitudes with people\u2019s opinion of depression as a valid reason for sickness absence: a Swedish vignette study","volume":"73","author":"Bertilsson","year":"2022","journal-title":"Work"},{"key":"ref37","volume-title":"Clinical guideline for the diagnosis and management of work-related mental health conditions in general practice","author":"Mazza","year":"2019"},{"key":"ref38","unstructured":"2017"},{"key":"ref39","volume-title":"Technical report for the clinical practice guideline for the diagnosis and management of work-related mental health conditions in general practice","author":"Mazza","year":"2019"},{"key":"ref40","volume-title":"Administrative report for clinical guideline for the diagnosis and management of work-related mental health conditions in general practice","author":"Mazza","year":"2019"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"CD006237","DOI":"10.1002\/14651858.CD006237.pub4","article-title":"Interventions to improve return to work in depressed people","volume":"10","author":"Nieuwenhuijsen","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"key":"ref42","volume-title":"Diagnostic and statistical manual of mental disorders (DSM-5)","year":"2013"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1002\/da.22360","article-title":"Detection of anxiety disorders in primary care: a meta-analysis of assisted and unassisted diagnoses","volume":"32","author":"Olariu","year":"2015","journal-title":"Depress Anxiety"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/S0140-6736(09)60879-5","article-title":"Clinical diagnosis of depression in primary care: a meta-analysis","volume":"374","author":"Mitchell","year":"2009","journal-title":"Lancet"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.1176\/appi.ajp.157.11.1873","article-title":"Development and validation of a screening instrument for bipolar spectrum disorder: the mood disorder questionnaire","volume":"157","author":"Hirschfeld","year":"2000","journal-title":"Am J Psychiatry"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1017\/s0033291704002892","article-title":"The World Health Organization adult ADHD self-report scale (ASRS): a short screening scale for use in the general population","volume":"35","author":"Kessler","year":"2005","journal-title":"Psychol Med"},{"key":"ref47","volume-title":"The alcohol use disorders identification test: guidelines for use in primary care","author":"Babor","year":"2001"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"100062","DOI":"10.1016\/j.jadr.2020.100062","article-title":"Screening for major depressive disorder in a tertiary mental health Centre using EarlyDetect: a machine learning-based pilot study","volume":"3","author":"Liu","year":"2021","journal-title":"J Affect Dis Rep"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"100215","DOI":"10.1016\/j.jadr.2021.100215","article-title":"Screening for bipolar disorder in a tertiary mental health Centre using EarlyDetect: a machine learning-based pilot study","volume":"6","author":"Liu","year":"2021","journal-title":"J Affect Dis Rep"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1177\/10870547221136228","article-title":"Screening for aulthood ADHD and comorbidities in a tertiary mental health center using earlydetect: a machine learning-based pilot study","volume":"27","author":"Liu","year":"2023","journal-title":"J Atten Disord"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.psychres.2018.08.033","article-title":"The clinical relationship between cognitive impairment and psychosocial functioning in major depressive disorder: a systematic review","volume":"269","author":"Cambridge","year":"2018","journal-title":"Psychiatry Res"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.2147\/NDT.S206825","article-title":"Patient-reported depression severity and cognitive symptoms as determinants of functioning in patients with major depressive disorder: a secondary analysis of the 2-year prospective PERFORM study","volume":"15","author":"Haro","year":"2019","journal-title":"Neuropsychiatr Dis Treat"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.jad.2017.06.036","article-title":"Cognitive impairment as measured by the THINC-integrated tool (THINC-it): association with psychosocial function in major depressive disorder","volume":"222","author":"Cha","year":"2017","journal-title":"J Affect Disord"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"1","DOI":"10.9758\/cpn.2016.14.1.1","article-title":"Cognitive deficits as a mediator of poor occupational function in remitted major depressive disorder patients","volume":"14","author":"Woo","year":"2016","journal-title":"Clin Psychopharmacol Neurosci"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.comppsych.2014.08.051","article-title":"The impact of cognitive impairment on perceived workforce performance: results from the international mood disorders collaborative project","volume":"56","author":"McIntyre","year":"2015","journal-title":"Compr Psychiatry"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1002\/da.22063","article-title":"Cognitive deficits and functional outcomes in major depressive disorder: determinants, substrates, and treatment interventions","volume":"30","author":"McIntyre","year":"2013","journal-title":"Depress Anxiety"},{"key":"ref57","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.jpsychires.2022.07.036","article-title":"Association between baseline cognitive symptoms and the subsequent presenteeism and global function in patients with major depressive disorder","volume":"154","author":"Watanabe","year":"2022","journal-title":"J Psychiatr Res"},{"key":"ref58","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1017\/S1092852918000913","article-title":"Assessment in work productivity and the relationship with cognitive symptoms (AtWoRC): primary analysis from a Canadian open-label study of vortioxetine in patients with major depressive disorder (MDD)","volume":"24","author":"Chokka","year":"2019","journal-title":"CNS Spectr"},{"key":"ref59","doi-asserted-by":"publisher","first-page":"2861","DOI":"10.2147\/NDT.S175188","article-title":"Psychometric validation of the perceived deficits questionnaire-depression (PDQ-D) instrument in US and UK respondents with major depressive disorder","volume":"14","author":"Lam","year":"2018","journal-title":"Neuropsychiatr Dis Treat"},{"key":"ref60","first-page":"99","article-title":"A survey of multiple sclerosis. Part 1. Perceived cognitive problems and compensatory strategy use","volume":"4","author":"Sullivan","year":"1990","journal-title":"Can J Rehabil"},{"key":"ref61","doi-asserted-by":"publisher","first-page":"e1736","DOI":"10.1002\/mpr.1736","article-title":"Stability, reliability, and validity of the THINC-it screening tool for cognitive impairment in depression: a psychometric exploration in healthy volunteers","volume":"27","author":"Harrison","year":"2018","journal-title":"Int J Methods Psychiatr Res"},{"key":"ref62","doi-asserted-by":"publisher","first-page":"873","DOI":"10.4088\/JCP.16m11329","article-title":"The THINC-integrated tool (THINC-it) screening assessment for cognitive dysfunction: validation in patients with major depressive disorder","volume":"78","author":"McIntyre","year":"2017","journal-title":"J Clin Psychiatry"},{"key":"ref63","first-page":"135","article-title":"Rapid screening for perceived cognitive impairment in major depressive disorder","volume":"25","author":"Iverson","year":"2013","journal-title":"Ann Clin Psychiatry"},{"key":"ref64","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.psychres.2017.04.014","article-title":"Internal consistency and concurrent validity of the Montreal cognitive assessment in individuals with major depressive disorder","volume":"253","author":"Srisurapanont","year":"2017","journal-title":"Psychiatry Res"},{"key":"ref65","first-page":"176","article-title":"What is the overlap between subjective and objective cognitive impairments in MDD?","volume":"30","author":"Fava","year":"2018","journal-title":"Ann Clin Psychiatry"},{"key":"ref66","doi-asserted-by":"publisher","first-page":"3901","DOI":"10.1038\/s41598-017-04353-w","article-title":"Discrepancy between objective and subjective cognition in adults with major depressive disorder","volume":"7","author":"Srisurapanont","year":"2017","journal-title":"Sci Rep"},{"key":"ref67","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1093\/geronb\/gbw207","article-title":"Subjective cognitive decline correlates with depression symptoms and not with concurrent objective cognition in a clinic-based sample of older adults","volume":"73","author":"Zlatar","year":"2018","journal-title":"J Gerontol B Psychol Sci Soc Sci"},{"key":"ref68","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1017\/S1092852919000786","article-title":"Long-term functioning outcomes are predicted by cognitive symptoms in working patients with major depressive disorder treated with vortioxetine: results from the AtWoRC study","volume":"24","author":"Chokka","year":"2019","journal-title":"CNS Spectr"},{"key":"ref69","unstructured":"2015"},{"key":"ref70","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1186\/s12889-015-1954-4","article-title":"A systematic review including meta-analysis of work environment and depressive symptoms","volume":"15","author":"Theorell","year":"2015","journal-title":"BMC Public Health"},{"key":"ref71","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1001\/jamapsychiatry.2020.0322","article-title":"Psychosocial stressors at work and the risk of sickness absence due to a diagnosed mental disorder: a systematic review and meta-analysis","volume":"77","author":"Duchaine","year":"2020","journal-title":"JAMA Psychiat"},{"key":"ref72","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1097\/00004850-199606003-00015","article-title":"The measurement of disability","volume":"11","author":"Sheehan","year":"1996","journal-title":"Int Clin Psychopharmacol"},{"key":"ref73","unstructured":"2018"},{"key":"ref74","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/j.jad.2018.11.034","article-title":"Validation of the University of California san Diego Performance-based skills assessment (UPSA) in major depressive disorder: replication and extension of initial findings","volume":"245","author":"Christensen","year":"2019","journal-title":"J Affect Disord"},{"key":"ref75","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1097\/00005650-200101000-00009","article-title":"The work limitations questionnaire","volume":"39","author":"Lerner","year":"2001","journal-title":"Med Care"},{"key":"ref76","doi-asserted-by":"publisher","first-page":"353","DOI":"10.2165\/00019053-199304050-00006","article-title":"The validity and reproducibility of a work productivity and activity impairment instrument","volume":"4","author":"Reilly","year":"1993","journal-title":"PharmacoEconomics"},{"key":"ref77","doi-asserted-by":"publisher","first-page":"110249","DOI":"10.1016\/j.jpsychores.2020.110249","article-title":"The occupational depression inventory: a new tool for clinicians and epidemiologists","volume":"138","author":"Bianchi","year":"2020","journal-title":"J Psychosom Res"},{"key":"ref78","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1002\/smi.3177","article-title":"Towards a new approach to job-related distress: a three-sample study of the occupational depression inventory","volume":"39","author":"Bianchi","year":"2023","journal-title":"Stress Health"},{"key":"ref79","unstructured":"2020"},{"key":"ref80","doi-asserted-by":"publisher","first-page":"284","DOI":"10.3389\/fpsyg.2019.00284","article-title":"The relationship between burnout, depression, and anxiety: a systematic review and meta-analysis","volume":"10","author":"Koutsimani","year":"2019","journal-title":"Front Psychol"},{"key":"ref81","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1136\/oemed-2019-106094","article-title":"Is burn-out finally a disease or not?","volume":"76","author":"Durand-Moreau","year":"2019","journal-title":"Occup Environ Med"},{"key":"ref82","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.burn.2014.03.003","article-title":"Relationship between burnout and depressive symptoms: a study using the person-centred approach","volume":"1","author":"Ahola","year":"2014","journal-title":"Burn Res"},{"key":"ref83","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1177\/2167702620979597","article-title":"Is burnout a depressive condition? A 14-sample meta-analytic and bifactor analytic study","volume":"9","author":"Bianchi","year":"2021","journal-title":"Clin Psycholog Sci"},{"key":"ref84","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.jad.2022.06.047","article-title":"Relationship between burnout and major depressive disorder in health professionals: a HEAR report","volume":"312","author":"Zisook","year":"2022","journal-title":"J Affect Disord"},{"key":"ref85","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1002\/wps.20311","article-title":"Understanding the burnout experience: recent research and its implications for psychiatry","volume":"15","author":"Maslach","year":"2016","journal-title":"World Psychiatry"},{"key":"ref86","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1002\/job.4030020205","article-title":"The measurement of experienced burnout","volume":"2","author":"Maslach","year":"1981","journal-title":"J Occupat Behav"},{"key":"ref87","volume-title":"The Maslach burnout inventory-test manual","author":"Maslach","year":"1996"},{"key":"ref88","doi-asserted-by":"publisher","first-page":"796401","DOI":"10.3389\/fpubh.2021.796401","article-title":"From burnout to occupational depression: recent developments in research on job-related distress and occupational health","volume":"9","author":"Schonfeld","year":"2021","journal-title":"Front Public Health"},{"key":"ref89","doi-asserted-by":"publisher","first-page":"249","DOI":"10.3389\/fpsyt.2018.00249","article-title":"The detection of malingering: a new tool to identify made-up depression","volume":"9","author":"Monaro","year":"2018","journal-title":"Front Psych"},{"key":"ref90","first-page":"1458","article-title":"Factitious disorders and malingering","volume-title":"Rosen\u2019s emergency medicine","author":"Heer","year":"2010"},{"key":"ref91","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1136\/practneurol-2018-001950","article-title":"Malingering and factitious disorder","volume":"19","author":"Bass","year":"2019","journal-title":"Pract Neurol"},{"key":"ref92","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1016\/S0140-6736(13)62186-8","article-title":"Factitious disorders and malingering: challenges for clinical assessment and management","volume":"383","author":"Bass","year":"2014","journal-title":"Lancet"},{"key":"ref93","first-page":"29","article-title":"Malingering","volume":"2","author":"Conroy","year":"2006","journal-title":"Appl Psychol Criminal Justice"},{"key":"ref94","doi-asserted-by":"publisher","first-page":"e134","DOI":"10.7417\/CT.2019.2123","article-title":"Lying in the medicolegal field: malingering and psychodiagnostic assessment","volume":"170","author":"Cassano","year":"2019","journal-title":"Clin Ter"},{"key":"ref95","doi-asserted-by":"publisher","first-page":"1878","DOI":"10.1080\/13854046.2020.1856414","article-title":"Examination of the MMPI-3 over-reporting scales in a forensic disability sample","volume":"36","author":"Tylicki","year":"2022","journal-title":"Clin Neuropsychol"},{"key":"ref96","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.jad.2015.03.004","article-title":"Long-term work disability and absenteeism in anxiety and depressive disorders","volume":"178","author":"Hendriks","year":"2015","journal-title":"J Affect Disord"},{"key":"ref97","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1176\/appi.ajp.2007.06111868","article-title":"Difference in treatment outcome in outpatients with anxious versus nonanxious depression: a STAR*D report","volume":"165","author":"Fava","year":"2008","journal-title":"Am J Psychiatry"},{"key":"ref98","doi-asserted-by":"publisher","first-page":"40511","DOI":"10.1038\/srep40511","article-title":"Comorbid generalized anxiety disorder and its association with quality of life in patients with major depressive disorder","volume":"7","author":"Zhou","year":"2017","journal-title":"Sci Rep"},{"key":"ref99","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1097\/NMD.0b013e3182043b60","article-title":"Distinctive clinical characteristics and suicidal tendencies of patients with anxious depression","volume":"199","author":"Seo","year":"2011","journal-title":"J Nerv Ment Dis"},{"key":"ref100","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1097\/YCO.0000000000000376","article-title":"Patients with anxious depression: overview of prevalence, pathophysiology and impact on course and treatment outcome","volume":"31","author":"Gaspersz","year":"2018","journal-title":"Curr Opin Psychiatry"},{"key":"ref101","first-page":"3","article-title":"Concurrent mental and substance use disorders in Canada","volume":"28","author":"Khan","year":"2017","journal-title":"Health Rep"},{"key":"ref102","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.jad.2019.11.146","article-title":"Epidemiology of physical and mental comorbidity in Canada and implications for health-related quality of life, suicidal ideation, and healthcare utilization: a nationwide cross-sectional study","volume":"263","author":"Dai","year":"2020","journal-title":"J Affect Disord"},{"key":"ref103","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1017\/S204579601600072X","article-title":"Patterns of association of chronic medical conditions and major depression","volume":"27","author":"Patten","year":"2018","journal-title":"Epidemiol Psychiatr Sci"},{"key":"ref104","doi-asserted-by":"publisher","first-page":"e0255907","DOI":"10.1371\/journal.pone.0255907","article-title":"Functional limitations in people with multimorbidity and the association with mental health conditions: baseline data from the Canadian longitudinal Study on aging (CLSA)","volume":"16","author":"Fisher","year":"2021","journal-title":"PLoS One"},{"key":"ref105","doi-asserted-by":"publisher","first-page":"e0215354","DOI":"10.1371\/journal.pone.0215354","article-title":"What are they returning to? Psychosocial work environment as a predictor of returning to work among employees in treatment for common mental disorders: a prospective observational pre-post study","volume":"14","author":"Lau","year":"2019","journal-title":"PLoS One"},{"key":"ref106","unstructured":"2001"},{"key":"ref107","doi-asserted-by":"crossref","DOI":"10.1001\/978-1-57947-888-9","volume-title":"Guides to the evaluation of permanent impairment","author":"Rondinelli","year":"2008"},{"key":"ref108","unstructured":"2021"},{"key":"ref109","unstructured":"2013"},{"key":"ref110","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1038\/mp.2015.53","article-title":"Consistent superiority of selective serotonin reuptake inhibitors over placebo in reducing depressed mood in patients with major depression","volume":"21","author":"Hieronymus","year":"2016","journal-title":"Mol Psychiatry"},{"key":"ref111","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1016\/S0140-6736(17)32802-7","article-title":"Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis","volume":"391","author":"Cipriani","year":"2018","journal-title":"Lancet"},{"key":"ref112","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1177\/0706743716659417","article-title":"Canadian network for mood and anxiety treatments (CANMAT) 2016 clinical guidelines for the management of adults with major depressive disorder: section 3","volume":"61","author":"Kennedy","year":"2016","journal-title":"Pharmacol Treatment Can J Psychiatry"},{"key":"ref113","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1093\/ijnp\/pyv082","article-title":"The cognitive effects of antidepressants in major depressive disorder: a systematic review and meta-analysis of randomized clinical trials","volume":"19","author":"Rosenblat","year":"2015","journal-title":"Int J Neuropsychopharmacol"},{"key":"ref114","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.jad.2017.11.003","article-title":"Efficacy of antidepressants on measures of workplace functioning in major depressive disorder: a systematic review","volume":"227","author":"Lee","year":"2018","journal-title":"J Affect Disord"},{"key":"ref115","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1007\/s40263-016-0334-7","article-title":"The effects of newer antidepressants on occupational impairment in major depressive disorder: a systematic review and meta-analysis of randomized controlled trials","volume":"30","author":"Evans","year":"2016","journal-title":"CNS Drugs"},{"key":"ref116","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.jad.2017.02.029","article-title":"Restoring function in major depressive disorder: a systematic review","volume":"215","author":"Sheehan","year":"2017","journal-title":"J Affect Disord"},{"key":"ref117","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1017\/S1092852921000171","article-title":"Comparative efficacy of pharmacological treatments on measures of self-rated functional outcomes using the Sheehan disability scale in patients with major depressive disorder: a systematic review and network meta-analysis","volume":"2021","author":"Cao","year":"2021","journal-title":"CNS Spectr"},{"key":"ref118","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.euroneuro.2015.09.006","article-title":"Sustained efficacy of agomelatine 10 mg, 25 mg, and 25-50 mg on depressive symptoms and functional outcomes in patients with major depressive disorder. A placebo-controlled study over 6 months","volume":"26","author":"Kennedy","year":"2016","journal-title":"Eur Neuropsychopharmacol"},{"key":"ref119","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1185\/030079906X167453","article-title":"Duloxetine versus escitalopram and placebo in the treatment of patients with major depressive disorder: onset of antidepressant action, a non-inferiority study","volume":"23","author":"Nierenberg","year":"2007","journal-title":"Curr Med Res Opin"},{"key":"ref120","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1177\/0269881108089602","article-title":"Eight-week, placebo-controlled, double-blind comparison of the antidepressant efficacy and tolerability of bupropion XR and venlafaxine XR","volume":"23","author":"Hewett","year":"2009","journal-title":"J Psychopharmacol"},{"key":"ref121","doi-asserted-by":"publisher","first-page":"242","DOI":"10.4088\/JCP.12m08197","article-title":"Efficacy and safety of levomilnacipran sustained release 40 mg, 80 mg, or 120 mg in major depressive disorder: a phase 3, randomized, double-blind, placebo-controlled study","volume":"74","author":"Asnis","year":"2013","journal-title":"J Clin Psychiatry"},{"key":"ref122","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1177\/0269881109106953","article-title":"Double-blind, placebo-controlled comparison of the antidepressant efficacy and tolerability of bupropion XR and venlafaxine XR","volume":"24","author":"Hewett","year":"2010","journal-title":"J Psychopharmacol"},{"key":"ref123","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1503\/jpn.130040","article-title":"Levomilnacipran ER 40 mg and 80 mg in patients with major depressive disorder: a phase III, randomized, double-blind, fixed-dose, placebo-controlled study","volume":"39","author":"Bakish","year":"2014","journal-title":"J Psychiatry Neurosci"},{"key":"ref124","doi-asserted-by":"publisher","first-page":"363","DOI":"10.4088\/JCP.12m08141","article-title":"Efficacy and safety of levomilnacipran sustained release in moderate to severe major depressive disorder: a randomized, double-blind, placebo-controlled, proof-of-concept study","volume":"74","author":"Montgomery","year":"2013","journal-title":"J Clin Psychiatry"},{"key":"ref125","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1097\/YIC.0b013e32830cebed","article-title":"Efficacy, safety, and tolerability of fixed-dose desvenlafaxine 50 and 100 mg\/day for major depressive disorder in a placebo-controlled trial","volume":"23","author":"Boyer","year":"2008","journal-title":"Int Clin Psychopharmacol"},{"key":"ref126","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1097\/JCP.0000000000000060","article-title":"A phase III, double-blind, placebo-controlled, flexible-dose study of levomilnacipran extended-release in patients with major depressive disorder","volume":"34","author":"Sambunaris","year":"2014","journal-title":"J Clin Psychopharmacol"},{"key":"ref127","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1097\/JCP.0b013e31822c0a68","article-title":"Symptomatic and functional improvement in employed depressed patients: a double-blind clinical trial of desvenlafaxine versus placebo","volume":"31","author":"Dunlop","year":"2011","journal-title":"J Clin Psychopharmacol"},{"key":"ref128","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1185\/03007990802161923","article-title":"Efficacy, safety, and tolerability of desvenlafaxine 50 mg\/day and 100 mg\/day in outpatients with major depressive disorder","volume":"24","author":"Liebowitz","year":"2008","journal-title":"Curr Med Res Opin"},{"key":"ref129","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.euroneuro.2004.01.002","article-title":"Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial","volume":"14","author":"Detke","year":"2004","journal-title":"Eur Neuropsychopharmacol"},{"key":"ref130","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1097\/01.pra.0000426323.59698.64","article-title":"Efficacy and safety of desvenlafaxine 25 and 50 mg\/day in a randomized, placebo-controlled study of depressed outpatients","volume":"19","author":"Iwata","year":"2013","journal-title":"J Psychiatr Pract"},{"key":"ref131","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.eurpsy.2006.03.004","article-title":"Duloxetine in the treatment of major depressive disorder: a placebo- and paroxetine-controlled trial","volume":"21","author":"Perahia","year":"2006","journal-title":"Eur Psychiatry"},{"key":"ref132","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/1471-244X-13-94","article-title":"A double-blind, randomized, placebo-controlled study assessing the efficacy and tolerability of desvenlafaxine 10 and 50 mg\/day in adult outpatients with major depressive disorder","volume":"13","author":"Liebowitz","year":"2013","journal-title":"BMC Psychiatry"},{"key":"ref133","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.4088\/PCC.14m01711","article-title":"Efficacy of desvenlafaxine 50 mg\/d versus placebo in the long-term treatment of major depressive disorder: a randomized, double-blind trial","volume":"17","author":"Boyer","year":"2015","journal-title":"Prim Care Companion CNS Disord"},{"key":"ref134","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1097\/YIC.0000000000000018","article-title":"Efficacy and safety of vortioxetine (Lu AA21004), 15 and 20 mg\/day: a randomized, double-blind, placebo-controlled, duloxetine-referenced study in the acute treatment of adult patients with major depressive disorder","volume":"29","author":"Boulenger","year":"2014","journal-title":"Int Clin Psychopharmacol"},{"key":"ref135","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.1038\/npp.2015.52","article-title":"A randomized, placebo-controlled, active-reference, double-blind, flexible-dose study of the efficacy of vortioxetine on cognitive function in major depressive disorder","volume":"40","author":"Mahableshwarkar","year":"2015","journal-title":"Neuropsychopharmacology"},{"key":"ref136","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1185\/03007995.2011.609540","article-title":"Duloxetine versus placebo in the treatment of major depressive disorder and associated painful physical symptoms: a replication study","volume":"27","author":"Gaynor","year":"2011","journal-title":"Curr Med Res Opin"},{"key":"ref137","doi-asserted-by":"publisher","first-page":"583","DOI":"10.4088\/JCP.14m09337","article-title":"A randomized, double-blind, placebo-controlled study of the efficacy and safety of 2 doses of vortioxetine in adults with major depressive disorder","volume":"76","author":"Mahableshwarkar","year":"2015","journal-title":"J Clin Psychiatry"},{"key":"ref138","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1185\/03007995.2011.609539","article-title":"A randomized placebo-controlled trial of duloxetine in patients with major depressive disorder and associated painful physical symptoms","volume":"27","author":"Gaynor","year":"2011","journal-title":"Curr Med Res Opin"},{"key":"ref139","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1002\/hup.1262","article-title":"Assessment of depressive symptoms and functional outcomes in patients with major depressive disorder treated with duloxetine versus placebo: primary outcomes from two trials conducted under the same protocol","volume":"27","author":"Oakes","year":"2012","journal-title":"Hum Psychopharmacol"},{"key":"ref140","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1002\/hup.2424","article-title":"A randomised, double-blind study in adults with major depressive disorder with an inadequate response to a single course of selective serotonin reuptake inhibitor or serotonin-noradrenaline reuptake inhibitor treatment switched to vortioxetine or agomelatine","volume":"29","author":"Montgomery","year":"2014","journal-title":"Hum Psychopharmacol"},{"key":"ref141","doi-asserted-by":"publisher","first-page":"157","DOI":"10.2165\/00019053-199813010-00015","article-title":"Clinical and economic comparison of sertraline and fluoxetine in the treatment of depression. A 6-month double-blind study in a primary-care setting in France","volume":"13","author":"Boyer","year":"1998","journal-title":"PharmacoEconomics"},{"key":"ref142","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.psychres.2014.06.053","article-title":"The effect of bupropion XL and escitalopram on memory and functional outcomes in adults with major depressive disorder: results from a randomized controlled trial","volume":"220","author":"Soczynska","year":"2014","journal-title":"Psychiatry Res"},{"key":"ref143","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1185\/03007995.2015.1014028","article-title":"Comparison of vortioxetine versus venlafaxine XR in adults in Asia with major depressive disorder: a randomized, double-blind study","volume":"31","author":"Wang","year":"2015","journal-title":"Curr Med Res Opin"},{"key":"ref144","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1185\/030079907x210732","article-title":"A comparative study of the efficacy of acute and continuation treatment with escitalopram versus duloxetine in patients with major depressive disorder","volume":"23","author":"Wade","year":"2007","journal-title":"Curr Med Res Opin"},{"key":"ref145","doi-asserted-by":"publisher","first-page":"155","DOI":"10.2165\/00019053-200523020-00007","article-title":"Evaluation of the cost effectiveness of escitalopram versus venlafaxine XR in major depressive disorder","volume":"23","author":"Fernandez","year":"2005","journal-title":"PharmacoEconomics"},{"key":"ref146","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1097\/00004850-200405000-00002","article-title":"The cost-effectiveness of mirtazapine versus paroxetine in treating people with depression in primary care","volume":"19","author":"Romeo","year":"2004","journal-title":"Int Clin Psychopharmacol"},{"key":"ref147","doi-asserted-by":"publisher","first-page":"969","DOI":"10.2165\/00019053-200826110-00008","article-title":"Escitalopram and duloxetine in major depressive disorder: a pharmacoeconomic comparison using UK cost data","volume":"26","author":"Wade","year":"2008","journal-title":"PharmacoEconomics"},{"key":"ref148","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1097\/YIC.0b013e3280128d16","article-title":"Cost-effectiveness of escitalopram vs. citalopram in major depressive disorder","volume":"22","author":"Fantino","year":"2007","journal-title":"Int Clin Psychopharmacol"},{"key":"ref149","doi-asserted-by":"publisher","first-page":"608","DOI":"10.4088\/jcp.v59n1108","article-title":"The treatment of chronic depression, part 3: psychosocial functioning before and after treatment with sertraline or imipramine","volume":"59","author":"Miller","year":"1998","journal-title":"J Clin Psychiatry"},{"key":"ref150","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/0165-0327(91)90033-o","article-title":"Life satisfaction and psychosocial functioning in chronic depression: effect of acute treatment with antidepressants","volume":"23","author":"Agosti","year":"1991","journal-title":"J Affect Disord"},{"key":"ref151","doi-asserted-by":"publisher","first-page":"239","DOI":"10.2147\/NDT.S146098","article-title":"Functional impairment in patients with major depressive disorder: the 2-year PERFORM study","volume":"14","author":"Hammer-Helmich","year":"2018","journal-title":"Neuropsychiatr Dis Treat"},{"key":"ref152","doi-asserted-by":"publisher","first-page":"e94","DOI":"10.1097\/JOM.0000000000001805","article-title":"Improvements in workplace productivity in working patients with major depressive disorder: results from the AtWoRC atudy","volume":"62","author":"Chokka","year":"2020","journal-title":"J Occup Environ Med"},{"key":"ref153","doi-asserted-by":"publisher","first-page":"977560","DOI":"10.3389\/fpsyt.2022.977560","article-title":"Effectiveness of vortioxetine for major depressive disorder in real-world clinical practice: US cohort results from the global RELIEVE study","volume":"13","author":"Mattingly","year":"2022","journal-title":"Front Psych"},{"key":"ref154","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1177\/0706743720970860","article-title":"The Canadian network for mood and anxiety treatments (CANMAT) task force recommendations for the use of racemic ketamine in adults with major depressive disorder","volume":"66","author":"Swainson","year":"2021","journal-title":"Can J Psychiatr"},{"key":"ref155","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.jad.2021.06.032","article-title":"Efficacy of ketamine and esketamine on functional outcomes in treatment-resistant depression: a systematic review","volume":"293","author":"Ng","year":"2021","journal-title":"J Affect Disord"},{"key":"ref156","doi-asserted-by":"publisher","first-page":"113860","DOI":"10.1016\/j.psychres.2021.113860","article-title":"The effect of repeated doses of intravenous ketamine on measures of workplace attendance and productivity in adults with major depressive and bipolar disorder: results from the Canadian rapid treatment Center of Excellence","volume":"300","author":"Rodrigues","year":"2021","journal-title":"Psychiatry Res"},{"key":"ref157","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/s12875-015-0314-x","article-title":"Comparative effectiveness of psychological treatments for depressive disorders in primary care: network meta-analysis","volume":"16","author":"Linde","year":"2015","journal-title":"BMC Fam Pract"},{"key":"ref158","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1016\/j.cpr.2010.05.003","article-title":"Is cognitive-behavioral therapy more effective than other therapies? A meta-analytic review","volume":"30","author":"Tolin","year":"2010","journal-title":"Clin Psychol Rev"},{"key":"ref159","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1002\/wps.20346","article-title":"How effective are cognitive behavior therapies for major depression and anxiety disorders? A meta-analytic update of the evidence","volume":"15","author":"Cuijpers","year":"2016","journal-title":"World Psychiatry"},{"key":"ref160","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1177\/070674371305800702","article-title":"A meta-analysis of cognitive-behavioural therapy for adult depression, alone and in comparison with other treatments","volume":"58","author":"Cuijpers","year":"2013","journal-title":"Can J Psychiatr"},{"key":"ref161","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1002\/wps.21069","article-title":"Cognitive behavior therapy vs. control conditions, other psychotherapies, pharmacotherapies and combined treatment for depression: a comprehensive meta-analysis including 409 trials with 52,702 patients","volume":"22","author":"Cuijpers","year":"2023","journal-title":"World Psychiatry"},{"key":"ref162","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1177\/0706743716659418","article-title":"Canadian network for mood and anxiety treatments (CANMAT) 2016 clinical guidelines for the Management of Adults with major depressive disorder: section 2","volume":"61","author":"Parikh","year":"2016","journal-title":"Psychol Treatment Can J Psychiatry"},{"key":"ref163","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1017\/S0033291716002774","article-title":"The efficacy of psychotherapy, pharmacotherapy and their combination on functioning and quality of life in depression: a meta-analysis","volume":"47","author":"Kamenov","year":"2017","journal-title":"Psychol Med"},{"key":"ref164","doi-asserted-by":"publisher","first-page":"e512","DOI":"10.1097\/JOM.0000000000002267","article-title":"Digital mHealth interventions for employees: systematic review and meta-analysis of their effects on workplace outcomes","volume":"63","author":"Stratton","year":"2021","journal-title":"J Occup Environ Med"},{"key":"ref165","doi-asserted-by":"publisher","first-page":"e38903","DOI":"10.2196\/38903","article-title":"Testing the pragmatic effectiveness of a consumer-based mindfulness mobile app in the workplace: randomized controlled trial","volume":"10","author":"Huberty","year":"2022","journal-title":"JMIR Mhealth Uhealth"},{"key":"ref166","doi-asserted-by":"publisher","first-page":"e37776","DOI":"10.2196\/37776","article-title":"Trends in effectiveness of organizational eHealth interventions in addressing employee mental health: systematic review and meta-analysis","volume":"24","author":"Stratton","year":"2022","journal-title":"J Med Internet Res"},{"key":"ref167","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1007\/s10926-021-09991-6","article-title":"Healthy minds: group cognitive-behavioral intervention for sustainable return to work after a sick leave due to depression","volume":"32","author":"Corbi\u00e8re","year":"2022","journal-title":"J Occup Rehabil"},{"key":"ref168","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/s00420-018-1380-x","article-title":"Psychological treatments for return to work in individuals on sickness absence due to common mental disorders or musculoskeletal disorders: a systematic review and meta-analysis of randomized-controlled trials","volume":"92","author":"Finnes","year":"2019","journal-title":"Int Arch Occup Environ Health"},{"key":"ref169","doi-asserted-by":"publisher","first-page":"1954","DOI":"10.1017\/S0033291718000065","article-title":"Sickness absence: a systematic review and meta-analysis of psychological treatments for individuals on sick leave due to common mental disorders","volume":"48","author":"Salomonsson","year":"2018","journal-title":"Psychol Med"},{"key":"ref170","doi-asserted-by":"publisher","first-page":"e271","DOI":"10.2196\/jmir.7583","article-title":"Improving employee well-being and effectiveness: systematic review and meta-analysis of web-based psychological interventions delivered in the workplace","volume":"19","author":"Carolan","year":"2017","journal-title":"J Med Internet Res"},{"key":"ref171","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1177\/14034948221075016","article-title":"Internet-delivered cognitive behavioral therapy (iCBT) for common mental disorders and subsequent sickness absence: a systematic review and meta-analysis","volume":"51","author":"Udd-Granat","year":"2023","journal-title":"Scand J Public Health"},{"key":"ref172","unstructured":"BondG\n            LemerD\n            DrakeR\n            ReidyC\n            ChoiJ\n          2019"},{"key":"ref173","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10926-016-9690-x","article-title":"Effectiveness of workplace interventions in return-to-work for musculoskeletal, pain-related and mental health conditions: An update of the evidence and messages for practitioners","volume":"28","author":"Cullen","year":"2018","journal-title":"J Occup Rehabil"},{"key":"ref174","doi-asserted-by":"publisher","first-page":"790","DOI":"10.4088\/jcp.08m04241","article-title":"The DEMO trial: a randomized, parallel-group, observer-blinded clinical trial of strength versus aerobic versus relaxation training for patients with mild to moderate depression","volume":"70","author":"Krogh","year":"2009","journal-title":"J Clin Psychiatry"},{"key":"ref175","doi-asserted-by":"publisher","first-page":"e48316","DOI":"10.1371\/journal.pone.0048316","article-title":"DEMO-II trial. Aerobic exercise versus stretching exercise in patients with major depression\u2013a randomised clinical trial","volume":"7","author":"Krogh","year":"2012","journal-title":"PLoS One"},{"key":"ref176","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1192\/bjp.bp.114.160101","article-title":"Physical exercise and internet-based cognitive-behavioural therapy in the treatment of depression: randomised controlled trial","volume":"207","author":"Hallgren","year":"2015","journal-title":"Br J Psychiatry"},{"key":"ref177","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1136\/oemed-2017-104326","article-title":"Effects of internet-based cognitive behavioural therapy and physical exercise on sick leave and employment in primary care patients with depression: two subgroup analyses","volume":"75","author":"Kaldo","year":"2018","journal-title":"Occup Environ Med"},{"key":"ref178","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1007\/s10926-019-09861-2","article-title":"Stakeholders\u2019 role and actions in the return-to-work process of workers on sick-leave due to common mental disorders: a scoping review","volume":"30","author":"Corbi\u00e8re","year":"2020","journal-title":"J Occup Rehabil"},{"key":"ref179","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3390\/ijerph15020278","article-title":"Prevention of common mental disorders in employees. Perspectives on collaboration from three health care professions","author":"Rothermund","year":"2018","journal-title":"Int J Environ Res Public Health"},{"key":"ref180","unstructured":"2019"},{"key":"ref181","unstructured":"2017"},{"key":"ref182","unstructured":"Ch\u00e9nierL\n            BoyerC\n          2016"},{"key":"ref183","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s00420-019-01463-y","article-title":"Workplace bullying, mental distress, and sickness absence: the protective role of social support","volume":"93","author":"Nielsen","year":"2020","journal-title":"Int Arch Occup Environ Health"},{"key":"ref184","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1007\/s10926-019-09832-7","article-title":"Sustainable return to work: a systematic review focusing on personal and social factors","volume":"29","author":"Etuknwa","year":"2019","journal-title":"J Occup Rehabil"},{"key":"ref185","doi-asserted-by":"publisher","first-page":"119","DOI":"10.34172\/ijoem.2020.1870","article-title":"What could influence workers\u2019 decisions to disclose a mental illness at work?","volume":"11","author":"Dewa","year":"2020","journal-title":"Int J Occup Environ Med"},{"key":"ref186","doi-asserted-by":"publisher","first-page":"7791","DOI":"10.1080\/09638288.2021.1998667","article-title":"Disclosure dilemmas: how people with a mental health condition perceive and manage disclosure at work","volume":"44","author":"Toth","year":"2022","journal-title":"Disabil Rehabil"},{"key":"ref187","doi-asserted-by":"publisher","first-page":"221","DOI":"10.3233\/WOR-182737","article-title":"Critical factors for the return-to-work process among people with affective disorders: voices from two vocational approaches","volume":"60","author":"Porter","year":"2018","journal-title":"Work"},{"key":"ref188","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1007\/s10926-019-09848-z","article-title":"To disclose or not to disclose: a multi-stakeholder focus group study on mental health issues in the work environment","volume":"30","author":"Brouwers","year":"2020","journal-title":"J Occup Rehabil"},{"key":"ref189","first-page":"3","article-title":"Employee perceptions about factors influencing their return to work after a sick-leave due to depression","volume":"84","author":"Corbi\u00e8re","year":"2018","journal-title":"J Rehabil"},{"key":"ref190","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1007\/s10926-021-09977-4","article-title":"Implicit and explicit attitudes of employers toward hiring people who have experienced depression","volume":"31","author":"Yvon","year":"2021","journal-title":"J Occup Rehabil"},{"key":"ref191","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12888-015-0706-4","article-title":"The effectiveness of interventions targeting the stigma of mental illness at the workplace: a systematic review","volume":"16","author":"Hanisch","year":"2016","journal-title":"BMC Psychiatry"},{"key":"ref192","doi-asserted-by":"publisher","first-page":"581876","DOI":"10.3389\/fpsyt.2021.581876","article-title":"An ecological study of a universal employee depression awareness and stigma reduction intervention: \u201cright direction\u201d","volume":"12","author":"Doty","year":"2021","journal-title":"Front Psych"},{"key":"ref193","doi-asserted-by":"publisher","first-page":"39S","DOI":"10.1177\/0706743719842559","article-title":"The working mind: a meta-analysis of a workplace mental health and stigma reduction program","volume":"64","author":"Dobson","year":"2019","journal-title":"Can J Psychiatr"},{"key":"ref194","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1177\/0706743720961738","article-title":"Effects of the anti-stigma workplace intervention \u201cworking mind\u201d in a Canadian health-care setting: a cluster-randomized trial of immediate versus delayed implementation","volume":"66","author":"Dobson","year":"2021","journal-title":"Can J Psychiatr"},{"key":"ref195","unstructured":"2018"},{"key":"ref196","unstructured":"2020"},{"key":"ref197","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1176\/appi.ps.201300267","article-title":"The impact of job accommodations on employment outcomes among individuals with psychiatric disabilities","volume":"65","author":"Chow","year":"2014","journal-title":"Psychiatr Serv"},{"key":"ref198","first-page":"163","article-title":"Reasonable accommodations for workers with serious mental illness: type, frequency, and associated outcomes","volume":"17","author":"Fabian","year":"1993","journal-title":"Psychosocial Rehab J"},{"key":"ref199","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1023\/a:1013955830779","article-title":"An investigation of reasonable workplace accommodations for people with psychiatric disabilities: quantitative findings from a multi-site study","volume":"38","author":"MacDonald-Wilson","year":"2002","journal-title":"Community Ment Health J"},{"key":"ref200","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1037\/prj0000033","article-title":"Work accommodations and natural supports for maintaining employment","volume":"37","author":"Corbi\u00e8re","year":"2014","journal-title":"Psychiatr Rehabil J"},{"key":"ref201","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1007\/s10597-016-0068-5","article-title":"Work accommodations and natural supports for employees with severe mental illness in social businesses: An international comparison","volume":"53","author":"Villotti","year":"2017","journal-title":"Comm Mental Health J"},{"key":"ref202","doi-asserted-by":"publisher","first-page":"37","DOI":"10.7870\/cjcmh-2018-026","article-title":"Work accommodations in Canadian social firms: supervisors\u2019 and workers\u2019 perspectives","volume":"37","author":"Corbi\u00e8re","year":"2019","journal-title":"Can J Comm Mental Health"},{"key":"ref203","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/s10926-017-9715-0","article-title":"How can supervisors contribute to the return to work of employees who have experienced depression?","volume":"28","author":"Negrini","year":"2018","journal-title":"J Occup Rehabil"},{"key":"ref204","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1007\/s10926-017-9730-1","article-title":"Determinants of sickness absence and return to work among employees with common mental disorders: a scoping review","volume":"28","author":"De Vries","year":"2018","journal-title":"J Occup Rehabil"},{"key":"ref205","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s10926-020-09902-1","article-title":"Tools appraisal of organizational factors associated with return-to-work in workers on sick leave due to musculoskeletal and common mental disorders: a systematic search and review","volume":"31","author":"Villotti","year":"2021","journal-title":"J Occup Rehabil"},{"key":"ref206","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1007\/s10926-020-09935-6","article-title":"A systematic search and review of questionnaires measuring individual psychosocial factors predicting return to work after musculoskeletal and common mental disorders","volume":"31","author":"Gragnano","year":"2021","journal-title":"J Occup Rehabil"},{"key":"ref207","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/13651501.2022.2092515","article-title":"Factors associated with sick leave duration in patients suffering from major depressive disorder initiating antidepressant treatment: a real-world evidence study in Germany and Spain","volume":"2022","author":"Roca","year":"2022","journal-title":"Int J Psychiatry Clin Pract"},{"key":"ref208","unstructured":"2020"},{"key":"ref209","unstructured":"2020"},{"key":"ref210","unstructured":"2011"}],"container-title":["Frontiers in Psychiatry"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2023.1207653\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,5]],"date-time":"2023-09-05T09:18:42Z","timestamp":1693905522000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2023.1207653\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,5]]},"references-count":210,"alternative-id":["10.3389\/fpsyt.2023.1207653"],"URL":"https:\/\/doi.org\/10.3389\/fpsyt.2023.1207653","relation":{},"ISSN":["1664-0640"],"issn-type":[{"value":"1664-0640","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,5]]},"article-number":"1207653"}}